Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
43.82
+3.44 (8.52%)
Nov 1, 2024, 4:00 PM EDT - Market closed
Vera Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Vera Therapeutics stock have an average target of 53.56, with a low estimate of 25 and a high estimate of 107. The average target predicts an increase of 22.23% from the current stock price of 43.82.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for VERA stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 3 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $56 → $64 | Strong Buy | Maintains | $56 → $64 | +46.05% | Oct 28, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $60 | Buy | Initiates | $60 | +36.92% | Oct 16, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $107 | Buy | Reiterates | $107 | +144.18% | Oct 3, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $107 | Buy | Reiterates | $107 | +144.18% | Oct 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $107 | Buy | Reiterates | $107 | +144.18% | Sep 23, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.64
from -2.25
EPS Next Year
-2.89
from -2.64
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 85.8M | ||
| Avg | n/a | n/a | 40.8M | ||
| Low | n/a | n/a | 7.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.57 | -2.54 | -2.85 | ||
| Avg | -2.64 | -2.89 | -3.04 | ||
| Low | -2.75 | -3.54 | -3.35 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.